School of Chemistry, University of Bristol , Bristol BS8 1TS U.K.
AstraZeneca , Pharmaceutical Development, Silk Road Business Park, Macclesfield SK10 2NA U.K.
Org Lett. 2016 Aug 19;18(16):4124-7. doi: 10.1021/acs.orglett.6b02074. Epub 2016 Aug 10.
The ability to affect asymmetric reduction of heterocyclic β-aminoacrylates 1 (n = 1-3) has been assessed with pyrrolidine and piperidone variants generating the corresponding N-heterocyclic β(2)-amino acids 3b and 5b with high enantioselectivity (≥97% ee) using a Rh/WALPHOS catalyst combination. The use of the carboxylic acid substrate was essential; the corresponding esters do undergo reduction but led to racemic products. The seven-ring azepanone variant (as the carboxylic acid 9b) underwent reduction, but only a minimal level of asymmetric induction was observed.
已经评估了用吡咯烷和哌啶酮变体影响杂环β-氨基丙烯酸盐 1(n = 1-3)不对称还原的能力,使用 Rh/WALPHOS 催化剂组合,生成相应的 N-杂环β(2)-氨基酸 3b 和 5b,具有高对映选择性(≥97%ee)。羧酸底物的使用是必不可少的;相应的酯确实会发生还原反应,但导致外消旋产物。七元氮杂环庚酮变体(作为羧酸 9b)发生了还原,但观察到的不对称诱导程度很小。